Multiple Myeloma

The Pharmacy Times® Multiple Myeloma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancer that forms in a type of white blood cell.

Latest News

multiple myeloma
Phase 3 CEPHEUS Trial: DARA Plus VRd Is a Standard of Care for Frontline Treatment in Transplant-Ineligible Multiple Myeloma

December 9th 2024

Phase 3 GMMG-HD7 Trial: Assessing the Impact of Isatuximab on MRD Negativity and PFS in Multiple Myeloma
Phase 3 GMMG-HD7 Trial: Assessing the Impact of Isatuximab on MRD Negativity and PFS in Multiple Myeloma

December 9th 2024

Daratumumab Demonstrates Significant Benefit in High-Risk Smoldering Myeloma: Results from the Phase 3 AQUILA Study
Daratumumab Demonstrates Significant Benefit in High-Risk Smoldering Myeloma: Results from the Phase 3 AQUILA Study

December 8th 2024

 Lymphocyte life cycle concept | Image Credit: © Anastasiia - stock.adobe.com
Study Shows Comparable Safety, Efficacy of Idecabtagene Vicleucel in Older Patients

December 3rd 2024

Latest CME Events & Activities

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Recent Advances in BCMA-Directed Treatment in Multiple Myeloma: Insights and Application for Managed Care

1.0 Credits / Hematologic Cancer, Oncology

View More

Revolutionizing Multiple Myeloma Care: CAR T-Cell Therapy, Bispecific Antibodies, and Patient-Centered Strateg...

1.0 Credit / Oncology, Hematologic Cancer

View More

Optimizing JAK Inhibitor Therapy for Myelofibrosis: Insights for Oncology Pharmacists

1.0 Credit / Hematologic Cancer, Oncology

View More

Elevating Safety and Adherence in Chronic Myeloid Leukemia Through Oncology Pharmacist Expertise

1.0 Credit / Hematologic Cancer, Oncology

View More

Enhancing Bruton Tyrosine Kinase Inhibitor Outcomes in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: ...

1.0 Credit / Hematologic Cancer

View More

Navigating Chronic Lymphocytic Leukemia Therapy and Cardiovascular Comorbidities: Clinical Recommendations and...

1.0 Credit / Hematologic Cancer

View More

Optimizing Bispecific Antibody Utilization in Non-Hodgkin Lymphoma: Addressing Challenges in Community-Based C...

1.0 Credit / Hematologic Cancer, Oncology

View More

Balancing Innovation and Implementation: A Comprehensive Approach to CAR T, Bispecific Antibodies, and Operati...

1.0 Credit / Hematologic Cancer, Oncology

View More

New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes: Bridging Clinical Innovation and Pract...

1.0 Credit / Hematologic Cancer, Oncology

View More

Finding Balance Between Advancement and Application: A Guide for Community Oncology Pharmacists on CAR T-Cell ...

0.75 Credit / Oncology, Hematologic Cancer

View More

Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodi...

1.5 Credits / Oncology, Hematology, Hematologic Cancer

View More

Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Manage...

1.5 Credits / Hematology, Hematologic Cancer, Oncology

View More

Navigating Long-Term Toxicities of CAR T-Cell Therapy: Educational Insights for Oncology Pharmacists

1.25 Credits / Oncology, Hematologic Cancer

View More

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Overcoming Disparities in Multiple Myeloma Treatment: Empowering Pharmacists to Drive Change

1.0 Credit / Health Equity, Diversity & Inclusion, Hematologic Cancer, Hematology, Oncology

View More

Navigating Treatment Evolution in Myelofibrosis: Oncology Pharmacist's Strategies for JAK Inhibitor Optimizati...

1.0 Credit / Hematologic Cancer, Hematology, Oncology

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatme...

1.0 Credit / Hematologic Cancer, Oncology

View More

SimulatEd™: Patient-Centered Care to Improve Outcomes in Chronic Lymphocytic Leukemia

1.0 Credit / Hematologic Cancer

View More

Cytokine Release Syndrome With Bispecific Antibodies: A Pharmacist's Guide to Safe Management

1.0 Credit / Hematologic Cancer, Lung Cancer, Oncology

View More

A Pharmacist's Guide to the Safe and Effective Management of BTK and BCL-2 inhibitors in Chronic Lymphocytic L...

1.0 Credit / Hematologic Cancer, Oncology

View More

Closing Gaps in CLL Care: Managed Care Insights and Strategies

1.5 Credit / Hematologic Cancer, Oncology

View More

Guiding Bispecific Antibody Use in Non-Hodgkin Lymphoma: Integrating Evidence and Enhancing Care

1.5 Credits / Hematologic Cancer, Hematology, Oncology

View More

Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations

1.0 Credit / Hematologic Cancer, Oncology

View More